Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;62(5):640-6.
doi: 10.1002/acr.20034.

What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set

T Sanderson  1 , M Morris, M Calnan, P Richards, S Hewlett
Affiliations

What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set

T Sanderson et al. Arthritis Care Res (Hoboken). 2010 May.

Abstract

Objective: Function, patient global assessment, and pain are routinely measured in rheumatoid arthritis (RA) clinical trials. However, other patient-reported outcomes identified as important to patients in qualitative studies, such as fatigue and quality of life, are commonly not included, and modern treatment regimens may have changed patients' expectations of treatment outcomes. Our objective was to elicit patient priority treatment outcomes for pharmacologic interventions since the common use of anti-tumor necrosis factor (anti-TNF) therapy, which will form the basis of a core set of patient priorities to complement existing professional core sets.

Methods: In-depth interviews were conducted with 23 RA patients, purposively sampled for age, sex, medication (anti-TNF or other disease-modifying antirheumatic drugs), disease severity, and work status. Grounded theory guided iterative data collection and analysis. Coding of the data was peer reviewed. A patient research partner collaborated in the research design and analysis.

Results: Sixty-three different outcomes important to patients were generated from the interviews. Four major categories of patient outcomes from pharmacologic treatments were developed: "RA under control," "Doing things," "Emotional health," and "Coping with illness." The core category (or overall theme) was "Minimizing the personal impact of RA."

Conclusion: Although the routine outcomes of pain, function, and overall well-being were raised by the patients, they also generated a further 60 important outcomes that they look for from treatment. This difference in perspective may potentially influence treatment decisions. The next step is therefore to use these data to develop a patient core set.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Thematic framework of patient-generated treatment outcomes
See this image and copyright information in PMC

References

    1. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary cores set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum. 1993;36(6):729–40. - PubMed
    1. van der Heijde D, Hof M, Piet L, Putte L. Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol. 1993;20(3):579–81. - PubMed
    1. Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, et al. ICF core sets for rheumatoid arthritis. J Rehabil Med. 2004 Jul;(Supp(44)):87–93. - PubMed
    1. Kwoh CK, O’Connor GT, Regan-Smith MG, et al. Concordance between clinical and patient assessment of physical and mental health status. J Rheumatol. 1992;19:1031–7. - PubMed
    1. Berkanovic E, Hurwicz ML, Lachenbruch PA. Concordant and discrepant views of patients’ physical functioning. Arthritis Care Res. 1995;8:94–101. - PubMed

Publication types

Substances